Connect with us

Technology

Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery

Published

on

Funding from leading investors to accelerate R&D and international expansion to make robotic surgery solutions accessible to more

HONG KONG, Jan. 13, 2025 /PRNewswire/ — Cornerstone Robotics (the “Company”), a leading global innovator in surgical robotics, today announced that it has successfully raised over US$70 million in Series C financing led by EQT with participation from Qiming Venture Partners, Alpha JWC Ventures, the Innovation and Technology Venture Fund, eGarden Ventures, CTS Funds, K2VC, Long-Z Capital, etc.

This funding will accelerate the Company’s efforts in advancing the commercialization process, developing new surgical robotics products, conducting clinical trials, obtaining regulatory approvals, and promoting global adoption of advanced robotic surgical solutions.

In addition to receiving funding from a group of prominent investors, the Company headquartered in Hong Kong and the Greater Bay Area, also received investment from the Innovation and Technology Venture Fund under the Innovation and Technology Commission of the Hong Kong Special Administrative Region Government. The endorsement underscores confidence for Cornerstone Robotics’ product innovation and global commercialization capabilities. This backing will further enable the Company to expand into key geographies, including countries in Europe, Southeast Asia and across global markets.

Since its establishment in September 2019, Cornerstone Robotics has aimed to revolutionize healthcare by making advanced surgical systems accessible globally. Through in-house R&D and vertical supply chain integration, Cornerstone Robotics delivers high-quality performance at competitive prices, enabling partnerships with leading medical centers in mainland China, Hong Kong, and Europe, including the Faculty of Medicine of the Chinese University of Hong Kong, and Chinese University of Hong Kong-Shenzhen Medicine. The Company’s successful clinical trials in multiple specialties – including urology, general surgery, gynecology and thoracic surgeries – have built a solid foundation for international expansion.

In September 2024, Cornerstone Robotics achieved a significant milestone when it obtained the National Medical Products Administration (NMPA) approval in China for “Sentire”, its pioneering Endoscopic Surgical System. Additionally in 2024, Cornerstone Robotics established a site in the UK. This collaboration aims to foster cutting-edge innovation, support advanced research, and enhance the Company’s ability to serve patients in Europe and across global markets.

Professor Samuel Au, founder and CEO of Cornerstone Robotics, stated, “Cornerstone Robotics experienced several pivotal milestones over the past year. We are deeply grateful to our shareholders for their trust and support. This milestone is not only a recognition of our team’s efforts in translating surgical robotics innovations into practical applications but also a testament to our commitment to long-term, high-quality development. ‘Building the cornerstone of surgical robotics industry’ has been our aspiration since we began in 2019. After five years of efforts, we have achieved independent R&D and manufacturing, also received recognition from the NMPA in 2024. Moving forward, our team will continue to innovate, expand global markets, advance international certifications, and collaborate with more partners to create value for the intelligent healthcare industry and contribute to a better future for humanity.”

Excerpts from Investment Institutions’ Remarks

[EQT]

Clara Ho and Gordon Shaw, Partners in the EQT Private Capital Asia advisory team, said, “Globally, there is an urgent need to make high-quality robot-assisted surgical care accessible to patients, yet few companies have the capability to deliver the level of safety, precision, and rigor required for these critical procedures. Cornerstone Robotics stands out as a leader in this space, combining cutting-edge medical robotics with a focus on expanding access to care. EQT is proud to support Cornerstone Robotics by leveraging our deep expertise in healthcare, technology, and life sciences to help advance their mission of providing innovative and cost-effective surgical solutions to patients worldwide.”

[Qiming Venture Partners]

William Hu, Managing Partner of Qiming Venture Partners, said, “The development and clinical application of surgical robots continue to drive improved treatment outcomes. Since Qiming Venture Partners’ investment in Cornerstone Robotics, we have observed steady enhancements in the company’s product performance and the continuous growth of its team. We believe Cornerstone Robotics is well-positioned to deliver increasingly competitive products and greater clinical value to customers worldwide. We are delighted to continue our investment and support as we work together toward new milestones.”

[Alpha JWC Ventures]

Jefrey Joe, General Partner Alpha JWC Ventures, said, “Alpha JWC Ventures is excited to partner with Cornerstone Robotics in their journey to expand into Southeast Asia. We believe their innovative approach to surgical robotics aligns with the growing needs and opportunities in the healthcare sector. We are committed to supporting their growth and success to bring the highest standards of healthcare in the region.”

The financial advisor to the Company is UBS.

About Cornerstone Robotics

Cornerstone Robotics (CSR) is dedicated to delivering accessible surgical systems that allow patients around the world to benefit from the highest standards of care. Our first-generation Endoscopic Surgical System is developed entirely in-house and has received approval by China’s National Medical Products Administration (NMPA). With multiple manufacturing facilities established in Greater Bay Area and corresponding supply chain support, we offer safe and accessible surgical robots to the world.

To find out more information, please visit our website at https://www.csrbtx.com/en/ .

About EQT

EQT is a purpose-driven global investment organization with EUR 246 billion in total assets under management (EUR 134 billion in fee-generating assets under management), divided into two business segments: Private Capital and Real Assets. EQT owns portfolio companies and assets in Europe, Asia Pacific, and the Americas and supports them in achieving sustainable growth, operational excellence, and market leadership.

More info: www.eqtgroup.com

Follow EQT on LinkedIn, X, YouTube and Instagram

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 580 fast-growing and innovative companies. Over 210 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 80 portfolio companies that have achieved unicorn or super unicorn status.

About Alpha JWC Ventures

Alpha JWC Ventures is an early to growth-stage Southeast Asian venture capital firm. Its debut fund was launched in 2015 as Indonesia’s first independent and institutional early-stage venture capital fund. Over the years, Alpha JWC has established a strong reputation and clear positioning in the market as the leading venture capital firm with one of the region’s largest on-the-ground teams and a global network. The firm currently manages around US$ 650 million AUM – the largest early-stage fund in Southeast Asia – and 80+ active portfolio companies across Southeast Asia.

For more information, please visit https://www.alphajwc.com.

About Innovation and Technology Venture Fund

Innovation and Technology Venture Fund (ITVF), under the Innovation and Technology Commission of the Hong Kong Special Administrative Region Government, co-invests with venture capital funds selected as ITVF’s co-investment partners (CPs) at a matching ratio of approximately 1 (ITVF): 2 (CP) in eligible local innovation and technology (I&T) start-ups to enrich the local I&T ecosystem.  The ITVF enhanced scheme has been also launched to invest in start-ups of strategic industries.

To find out more information, please visit the website at https://www.itf.gov.hk/l-eng/ITVF.asp

About eGarden Ventures

eGarden Ventures is a venture capital firm specializing in early growth-stage companies within emerging sectors. We are committed to supporting dedicated startup founders, providing not only financial investment but also strategic resources and guidance to help businesses thrive post-investment.

About CTS Capital

CTS Capital is a multi-stage healthcare and life sciences investment institution. Managed by a team of seasoned professionals with deep insights into the healthcare industry and extensive expertise in private equity, CTS Capital is committed to partnering with exceptional entrepreneurs and scientists, and actively engaging in the growth of its portfolio companies to drive technological and commercial innovations in China’s healthcare sector and the global market.

Guided by a research-driven investment strategy, CTS Capital’s investment focus spans biotechnology, innovative therapeutics, innovative medical devices, precision diagnosis, healthcare services, and other cutting-edge technologies within the broader healthcare landscape.

Since its inception, CTS Capital has invested in several leading companies in their respective sectors, many of which have achieved successful public listing, including United Imaging (688271.SH), SinoCellTech (688520.SH), SinoBiological (301047.SZ), Giant Biogene (02367.HK), and Recbio (02179.HK).

About KV2C

Founded in 2010, K2VC is an early-stage venture capital firm devoted to promoting technology advancement, indutrial upgrade, business model innovation and consumer lifestyle revolution. K2VC manages both RMB and USD funds, with AUM over 10 billion RMB and 700 portfolios companies year to date.

The English name of K2VC, comes from the abbreviation of Mount chhogo ri. K2 is the second highest mountain in the world and known for being the most difficult to climb, which symbolizes the great pursuit of entrepreneurs to surpass themselves and challenge their limits. K2 wishes to be a mountain guide for the entrepreneurs, accompany them in every step of the climb, overcome the difficult and reach the peak.

K2VC manages two funds, K2 Angel Partners and K2 Venture Partners. Besides venture capital investment, K2 also promotes social progress by funding Non-for-profit organizations and social enterprises.

About Long-Z Capital

Founded in 2017, Long-Z Investments focuses on investment in the consumer and technology industries and strives to become an important supporter of top entrepreneurs in these two industries. Rooted in Meituan ecosystem, we boost unique and rich industrial resources and advantages. At present, we have managed three RMB funds and one USD fund, with funds under management exceeding 13 billion yuan. The investors include government-guided funds, the world’s top sovereign funds, pension funds, well-known FOFs, leading enterprises in the consumer industry, internet companies, alumni donation funds and well-known professional institutions. Since establishment eight years ago, we have invested in dozens of member enterprises, including Li Auto, Cornerstone Robotics, ProfoundBio, MIXUE Ice Cream & Tea, Good Me, HEYTEA, Manner Coffee, Moonshot AI, Unitree Robotics, Del Technology, RongSemi, Axera, EcoFlow and SICHAIN, etc.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/cornerstone-robotics-raises-over-us70-million-funding-to-forge-accessibility-in-robotic-surgery-302348634.html

SOURCE Cornerstone Robotics

Continue Reading

Technology

KSAT and Morehead State University Partner to Expand Lunar Communications Infrastructure

Published

on

By

Partnership strengthens the KSAT Lunar Network and supports deep space and lunar exploration

DENVER and MOREHEAD, Ky., Oct. 31, 2026 /PRNewswire/ — Kongsberg Satellite Services (KSAT), a leading provider of ground station networks and satellite operations, today announced a strategic partnership with Morehead State University (MSU) to enhance the KSAT Lunar Network, supporting the growing demand for communications and tracking services for deep space and lunar missions.

The partnership leverages MSU Space Science Center’s established deep space communications capabilities, including its 21-meter and 12-meter-class antennas in Morehead, Kentucky, to further increase the KSAT Lunar Network. Together, the partnership enables mission operators to maintain reliable links with spacecraft operating beyond Earth orbit by adding network capacity and resiliency over the Eastern United States.

“Partnering with MSU advances KSAT’s ability to deliver the communications infrastructure required for the accelerated demand for deep space and lunar missions. We are especially thrilled about this partnership as it helps enable science and exploration space missions today, while developing the next-generation workforce to support the long-term development of the U.S. cislunar economy,” said Dan Adams, General Manager of KSAT Inc.

“This partnership reflects our commitment to supporting the future of space exploration through innovation, education, and collaboration,” said Dr. Benjamin K. Malphrus, Executive Director of Space Science Center. “Working with KSAT provides exciting opportunities for our students and researchers while enabling us to contribute directly to the thriving commercial sector.”

KSAT and MSU share a strong commitment and heritage of supporting NASA’s Artemis program, most recently the Artemis II mission, and the broader science and exploration, as well as inspiring the next generation. In addition to expanding KSAT Lunar capabilities, the partnership will create even more opportunities for student involvement and workforce development through KSAT’s internship programs, helping prepare the next generation of engineers and space professionals for careers in the rapidly growing space sector.

About KSAT:

Kongsberg Satellite Services (KSAT) is the leading commercial provider of Ground Station Services, Earth Observation Services, and Satellite Operations Services. Headquartered in Tromsø, Norway, the company operates the largest commercial satellite ground station network worldwide, including facilities in Svalbard and Antarctica to provide unique southern hemisphere coverage. Through KSAT Inc., KSAT’s U.S. based full-capability subsidiary, KSAT delivers mission-critical infrastructure for customers in government, civil, and commercial space in the United States, as well as the global space industry. 

About MSU:
Morehead State University (MSU) is a comprehensive, regional university located in Appalachian Kentucky in the Daniel Boone National Forest. MSU is known for excellence in STEM fields and pre-professional programs. The Space Science Center is MSU’s Program of Distinction and manages a significant research and development portfolio in small satellite systems, having executed 7 smallsat missions to date. The Center operates a 21-meter ground station and a 12-meter tracking antenna that provides lunar tracking services and smaller aperture ground stations for satellite telecommunications support. The Center also supports innovative undergraduate, graduate and a Doctor of Engineering program in Space Systems Engineering.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ksat-and-morehead-state-university-partner-to-expand-lunar-communications-infrastructure-302925397.html

Continue Reading

Technology

Millennium Dental Technologies and Institute for Advanced Laser Dentistry Mourn Passing of Professor Raymond A. Yukna, DMD, MS (1942-2026)

Published

on

By

CERRITOS, Calif., Oct. 30, 2026 /PRNewswire/ — It is with profound sadness that Millennium Dental Technologies and the Institute for Advanced Laser Dentistry (IALD) mourn the passing of Professor Raymond A. Yukna, DMD, MS, world-renowned clinician, educator, researcher, mentor and cherished friend.

Throughout a remarkable career spanning academia, research, clinical practice and education, Dr. Yukna earned the admiration of colleagues worldwide for his unwavering commitment to scientific inquiry, clinical excellence and the advancement of patient care.

A Diplomate of both the American Board of Periodontology and the American Board of Oral Medicine, Professor of Advanced Periodontal Therapies at the University of Colorado School of Dental Medicine, Professor Emeritus at Louisiana State University, internationally recognized lecturer, and respected researcher, Dr. Yukna devoted his life to advancing the field of periodontics. His contributions helped shape modern periodontal therapy and influenced generations of clinicians, educators, and researchers worldwide.

His reputation for integrity, scientific rigor and thoughtful leadership made him one of the most trusted and respected voices in the specialty.

A DEFINING CHAPTER IN THE HISTORY OF THE LANAP® PROTOCOL

Dr. Yukna brought credibility, intellectual curiosity and scientific discipline that would help shape the future of the LANAP® protocol, a minimally invasive laser treatment for the treatment of moderate to severe periodontal disease. He engaged in thoughtful dialogue with Millennium Dental Technologies Co-Founders Robert H. Gregg II, DDS, and Delwin K. McCarthy, DDS, regarding the emerging science behind laser-assisted periodontal regeneration.

His groundbreaking research provided some of the earliest and most influential human histological evidence supporting the LANAP® protocol. Beginning with his International Association for Dental Research (IADR) abstract in 2003, followed by the submission of his landmark study to the International Journal of Periodontics and Restorative Dentistry (IJPRD) in 2006 and its publication in 2007, Dr. Yukna produced research that became a defining milestone in the scientific validation of the LANAP® protocol. His work demonstrated cementum-mediated new connective tissue attachment in humans and provided the periodontal community with compelling evidence supporting the protocol’s regenerative potential.

At a time when laser periodontal therapy was met with understandable skepticism by many within the specialty, Dr. Yukna’s willingness to objectively evaluate the science—and ultimately contribute his own landmark research—gave the LANAP® protocol a level of scientific credibility that helped change its trajectory. Many periodontists first embraced the LANAP® protocol because they trusted Dr. Yukna’s scientific integrity and respected his commitment to evidence-based dentistry.

His landmark study opened the door to broader acceptance of the LANAP® protocol within periodontics and laid the foundation for additional human histological studies, expanded university research efforts, and more than two decades of continued scientific investigation. The growing body of evidence supporting the LANAP® protocol today owes much to the foundation Dr. Yukna helped establish.

A TEACHER WHO SHAPED A GENERATION

Dr. Yukna’s influence extended far beyond the published literature. As an IALD Certified Instructor, he became one of the most influential educators in the history of the LANAP® protocol. He served as hands-on clinical instructor for approximately 350 LANAP-trained clinicians and lectured at roughly 130 Laser BootCamps™, helping educate well over 1,000 clinicians throughout his years with the IALD and Millennium Dental Technologies.

From the Denver BootCamps™ held during his tenure at the University of Colorado School of Dental Medicine to sessions conducted throughout New York and, later, at the facility in Cerritos, Dr. Yukna’s lectures, mentorship and quiet confidence inspired countless clinicians. His generosity in sharing his knowledge, his thoughtful guidance and his commitment to excellence helped shape the careers of an entire generation of LANAP clinicians.

A CHERISHED FRIEND

Beyond his extraordinary professional accomplishments was an even more extraordinary person. For Robert H. Gregg II, DDS and Dawn Gregg, DDS, Dr. Yukna and his wife, Charlotte, were not simply respected colleagues, they were dear friends. Over many years, they shared milestones, celebrated successes, supported one another through challenges and built a friendship that extended far beyond dentistry. In fact, when Dr. Robert Gregg and Dr. Dawn Gregg began their lives together as a couple, Dr. Yukna and Charlotte were among the very first people they chose to tell in person—reflecting the trust, respect and affection they shared.

Those privileged to know Dr. Yukna personally will remember far more than his curriculum vitae. They will remember his humility, kindness, generosity, wisdom, quiet confidence and unwavering integrity. He challenged those around him to pursue excellence, to follow the science wherever it led, and to never lose sight of the patients whose lives could be changed through innovation grounded in evidence.

HIS LEGACY LIVES ON

The LANAP® community, the periodontal profession, the IALD and the entire Millennium Dental Technologies family are better because of Dr. Yukna’s contributions.

His legacy lives on through the science he advanced, the clinicians he trained, the patients whose lives were improved by his work, and the countless colleagues and friends he inspired throughout his remarkable career.

Millennium Dental Technologies and the IALD extends deepest condolences to Charlotte and Dr. Yukna’s family, friends, colleagues, students and all those whose lives he touched.

Thank you, Dr. Yukna, for your leadership, your scholarship, your mentorship, your friendship, and your unwavering belief that scientific excellence could improve the lives of patients around the world.

ABOUT MILLENNIUM DENTAL TECHNOLOGIES, INC.

Headquartered in Cerritos, Calif., Millennium Dental Technologies is the developer of the LANAP protocol for treating periodontal disease and the manufacturer of the PerioLase MVP-7 variable-pulsed Nd:YAG dental laser. The company’s FDA-cleared LANAP protocol offers a more comfortable, less invasive alternative to conventional periodontal surgery while providing unique bone-building clinical results. Founding clinician Robert H. Gregg II, DDS, continues to lead the company with a vision to create better clinical outcomes for patients with periodontal disease while remaining true to its guiding principle: “It’s all about the patient.” For more information, visit www.lanap.com.

ABOUT THE INSTITUTE FOR ADVANCED LASER DENTISTRY

The Institute for Advanced Laser Dentistry is a nonprofit educational and research organization dedicated to advancing evidence-based clinical training in laser dentistry. Established in 1999, the IALD is nationally recognized for its continuing education programs as an ADA Continuing Education Recognition Program and Academy of General Dentistry Program Approval for Continuing Education provider. For more information, visit www.theiald.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/millennium-dental-technologies-and-institute-for-advanced-laser-dentistry-mourn-passing-of-professor-raymond-a-yukna-dmd-ms-1942-2026-302925319.html

SOURCE Millennium Dental Technologies, Inc.

Continue Reading

Technology

Okta Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

Published

on

By

NEW YORK, Oct. 30, 2026 /PRNewswire/ — S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600 effective prior to the opening of trading on Wednesday, November 4:

S&P MidCap 400 constituent Okta Inc. (NASD: OKTA) will replace Kenvue Inc. (NYSE: KVUE) in the S&P 500, S&P SmallCap 600 constituent Glaukos Corp. (NYSE: GKOS) will replace Okta in the S&P MidCap 400, and McGrath RentCorp (NASD: MGRC) will replace Glaukos in the S&P SmallCap 600. S&P 500 constituent Kimberly-Clark (NASD: KMB) is acquiring Kenvue in a deal expected to be completed soon, pending final closing conditions.Loar Holdings Inc. (NYSE: LOAR) will replace LiveRamp Holdings Inc. (NYSE: RAMP) in the S&P SmallCap 600. Publicis Groupe SA (Euronext Paris: PUB) is acquiring LiveRamp Holdings in a deal expected to close soon, pending final closing conditions.

Following is a summary of the changes that will take place prior to the open of trading on the effective date:

Effective Date

Index Name 

Action

Company Name

Ticker

GICS Sector

Nov 4, 2026

S&P 500

Addition

Okta

OKTA

Information Technology

Nov 4, 2026

S&P 500

Deletion

Kenvue

KVUE

Consumer Staples

Nov 4, 2026

S&P MidCap 400

Addition

Glaukos

GKOS

Health Care

Nov 4, 2026

S&P MidCap 400

Deletion

Okta

OKTA

Information Technology

Nov 4, 2026

S&P SmallCap 600

Addition

McGrath RentCorp

MGRC

Industrials

Nov 4, 2026

S&P SmallCap 600

Deletion

Glaukos

GKOS

Health Care

Nov 4, 2026

S&P SmallCap 600

Addition

Loar Holdings

LOAR

Industrials

Nov 4, 2026

S&P SmallCap 600

Deletion

LiveRamp Holdings

RAMP

Information Technology

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spglobal.com/spdji/en/. 

FOR MORE INFORMATION:

S&P Dow Jones Indices
index_services@spglobal.com

Media Inquiries
spdji.comms@spglobal.com

View original content:https://www.prnewswire.com/news-releases/okta-set-to-join-sp-500-others-to-join-sp-midcap-400-and-sp-smallcap-600-302925405.html

SOURCE S&P Dow Jones Indices

Continue Reading

Trending